ZIMV Key Statistics, Chart & Performance
The current stock price of ZIMV is 18.99 USD. In the past month the price increased by 0.42%. In the past year, price increased by 29.36%.
ZIMV Latest News, Press Relases and Analysis
ZIMV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.76 | 223.72B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.69 | 205.85B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.22 | 149.60B | ||
| SYK | STRYKER CORP | 28.27 | 142.33B | ||
| IDXX | IDEXX LABORATORIES INC | 59.95 | 60.48B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.58B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.75 | 50.34B | ||
| RMD | RESMED INC | 25.76 | 37.22B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.57 | 36.73B | ||
| DXCM | DEXCOM INC | 33.62 | 24.52B | ||
| PODD | INSULET CORP | 71.51 | 22.99B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12.06 | 19.32B |
Related stock screener links
About ZIMV
Company Profile
Zimvie, Inc. is a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Palm Beach Gardens, Florida and currently employs 1,770 full-time employees. The company went IPO on 2022-02-14. The company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. The company markets its products in about 50 countries.
Company Info
ZIMVIE INC
4555 Riverside Drive
Palm Beach Gardens FLORIDA US
Employees: 1770
Phone: 18003425454
ZIMVIE INC / ZIMV FAQ
Can you describe the business of ZIMVIE INC?
Zimvie, Inc. is a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Palm Beach Gardens, Florida and currently employs 1,770 full-time employees. The company went IPO on 2022-02-14. The company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. The company markets its products in about 50 countries.
Can you provide the latest stock price for ZIMVIE INC?
The current stock price of ZIMV is 18.99 USD.
Does ZIMV stock pay dividends?
ZIMV does not pay a dividend.
How is the ChartMill rating for ZIMVIE INC?
ZIMV has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is ZIMVIE INC (ZIMV) stock traded?
ZIMV stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of ZIMVIE INC (ZIMV)?
The PE ratio for ZIMVIE INC (ZIMV) is 20.64. This is based on the reported non-GAAP earnings per share of 0.92 and the current share price of 18.99 USD.
When does ZIMVIE INC (ZIMV) report earnings?
ZIMVIE INC (ZIMV) will report earnings on 2025-10-29, after the market close.
ZIMV Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ZIMV. When comparing the yearly performance of all stocks, ZIMV is one of the better performing stocks in the market, outperforming 94.85% of all stocks.
ZIMV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ZIMV. ZIMV has only an average score on both its financial health and profitability.
ZIMV Financial Highlights
Over the last trailing twelve months ZIMV reported a non-GAAP Earnings per Share(EPS) of 0.92. The EPS increased by 135.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| Debt/Equity | 0.53 |
ZIMV Forecast & Estimates
9 analysts have analysed ZIMV and the average price target is 16.32 USD. This implies a price decrease of -14.06% is expected in the next year compared to the current price of 18.99.
For the next year, analysts expect an EPS growth of 54.53% and a revenue growth 0.03% for ZIMV